1. Home
  2. AIT vs IBRX Comparison

AIT vs IBRX Comparison

Compare AIT & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

HOLD

Current Price

$286.01

Market Cap

9.7B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.37

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIT
IBRX
Founded
1923
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.4B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
AIT
IBRX
Price
$286.01
$7.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$302.00
$12.57
AVG Volume (30 Days)
302.4K
22.1M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
0.71%
N/A
EPS Growth
2.95
38.71
EPS
5.14
N/A
Revenue
$21,485,000.00
$113,288,000.00
Revenue This Year
$7.77
$88.59
Revenue Next Year
$5.41
$131.15
P/E Ratio
$55.74
N/A
Revenue Growth
N/A
668.31
52 Week Low
$212.00
$1.83
52 Week High
$296.70
$12.43

Technical Indicators

Market Signals
Indicator
AIT
IBRX
Relative Strength Index (RSI) 67.32 47.68
Support Level $254.61 $2.25
Resistance Level $296.70 $8.28
Average True Range (ATR) 7.90 0.82
MACD 3.39 -0.08
Stochastic Oscillator 97.63 27.33

Price Performance

Historical Comparison
AIT
IBRX

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: